Tariman, Zameerah Blaire D.
HRN: 23-33-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
CEFUROXIME 750MG (VIAL)
09/21/2023
09/28/2023
IV
300mg
TID
UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes